Miso Chip

The company is the result of the best clinical and scientific research at the CHUM and Polytechnique in Montreal. The company's vision is to become a medical diagnostic company in oncology by 2025. Its mission is to help oncologists and their cancer patients to make the best personalized therapeutic choices before the start of treatment and to participate in the effort to control the costs of health care systems. Starting in 2020, based on its patented technology, MISO Chip markets its microfluidic devices and innovative services for drug research and development to academic laboratories, Biotechs and Pharma companies active in oncology.